Fred Hutchinson

American Society for Transplantation and Cellular Therapy presented awards to three leaders in the fields.

Philip D. Greenberg, MD, FAACR, has been elected American Association for Cancer Research president-elect for 2022-2023.

Brenda M. Sandmaier, MD, has been named the 2022-2023 president of American Society for Transplantation and Cellular Therapy.

SALT LAKE CITY — Ibrutinib appeared safe and effective for children with previously untreated or relapsed/refractory chronic graft-versus-host disease, according to study results.

SALT LAKE CITY — Zanubrutinib improved outcomes compared with bendamustine/rituximab among adults with treatment-naive deletion 17p-negative chronic lymphocytic leukemia or small lymphocytic lymphoma, according to phase 3 study results.

Women with breast cancer exhibited higher risk for heart failure, cardiomyopathy and other cardiovascular disease events than women without breast cancer, according to prospective study results published in Journal of Clinical Oncology.

More than 70% of patients with metastatic colorectal cancer bore financial hardships within the first year of diagnosis despite most having health insurance, according to study results published in Journal of the National Cancer Institute.

Sotorasib demonstrated clinically meaningful anticancer activity in patients with heavily pretreated KRAS G12C-mutated advanced pancreatic cancer, according to study results presented during the ASCO Plenary Series.

The Fred Hutch/University of Washington Cancer Consortium has announced new leadership.

Depletion of naive T cells from peripheral blood stem cell grafts resulted in very low incidence of severe acute and any graft-versus-host disease in three phase 2 clinical trials, according to a study in Journal of Clinical Oncology.